NEW YORK — Skechers, the Manhattan Beach, Calif.-based trendy footwear firm, is launching a line of junior sportswear slated to hit stores for next year’s back-to-school season.

Called Somethin’ Else from Skechers, the line is licensed to Federal Jeans Inc., which designs and develops branded sportswear for children, juniors’ and junior-plus sizes for multiple levels of distribution in the U.S., Canada and select international markets. Based in New York, Federal Jeans will design, distribute and market coordinated junior tops and bottoms in denim, knit and woven materials using the Somethin’ Else from Skechers logo. The line will be priced to target junior consumers with T-shirts retailing from $18 to $29 and jeans from $29 to $48.

“Juniors are known for sparking market trends,” said Michael Greenberg, president of Skechers USA. “It’s this same demographic who clamored for Skechers and took our appeal to an entirely new level. Offering a Somethin’ Else from Skechers branded clothing line that reflects their fashion-forward style is a natural step for our brand and a great opportunity for young women to embrace our image and further expose Skechers to their parents and siblings.”

Since its launch nearly three years ago, the Somethin’ Else from Skechers shoe line has grown from several styles into a diverse offering of casual and dress-casual footwear for teens. The shoe line is available at major department and specialty stores in the U.S., as well as in select markets globally.

In the past year, Skechers has diversified its licensing agreements to reflect its various footwear lines for women, men and children. The brand has licensing agreements with Kids Headquarters for children’s apparel, Renfro Corp. for socks, Advance Group Inc. for women’s and men’s sport watches, Garson International for men’s jackets and coats, Mitsui & Co. for women’s and men’s apparel in Japan, and Multigroup for infants, toddlers and children’s wear in Canada.

To access this article, click here to subscribe or to log in.

load comments
blog comments powered by Disqus